Volume 11 - Issue 3 - March 2014
03/05/2014
The Valiant Mona LSA stent graft system is the first device of its kind to be studied in humans as part of the FDA’s Innovation Pathway early feasibility pilot program.
The Valiant Mona LSA stent graft system is the first device of its kind to be studied in humans as part of the FDA’s Innovation Pathway early feasibility pilot program.
The Valiant Mona LSA stent graft...
03/05/2014
Vascular Disease Management
03/05/2014
The Valiant Mona LSA stent graft system is the first device of its kind to be studied in humans as part of the FDA’s Innovation Pathway early feasibility pilot program.
The Valiant Mona LSA stent graft system is the first device of its kind to be studied in humans as part of the FDA’s Innovation Pathway early feasibility pilot program.
The Valiant Mona LSA stent graft...
03/05/2014
Vascular Disease Management
03/05/2014
Barry S. Weinstock, MD
Orlando Regional Medical Center, Orlando, Florida
Barry S. Weinstock, MD
Orlando Re...
The author discusses established and evolving strategies to decrease the risk of contrast nephropathy.
The author discusses established and evolving strategies to decrease the risk of contrast nephropathy.
The author discusses established...
03/05/2014
Vascular Disease Management
03/05/2014
Carlos F. Bechara, MD, MS
Baylor College of Medicine, Houston, Texas
Carlos F. Bechara, MD, MS
Baylor ...
The author examines retrospective single-center data on the spiral laminar flow graft for lower extremity bypass.
The author examines retrospective single-center data on the spiral laminar flow graft for lower extremity bypass.
The author examines...
03/05/2014
Vascular Disease Management
03/05/2014
Technology is improving that could help to reduce the incidence of contrast-induced nephropathy.
Technology is improving that could help to reduce the incidence of contrast-induced nephropathy.
Technology is improving that...
03/05/2014
Vascular Disease Management
03/05/2014
Technology is improving that could help to reduce the incidence of contrast-induced nephropathy.
Technology is improving that could help to reduce the incidence of contrast-induced nephropathy.
Technology is improving that...
03/05/2014
Vascular Disease Management
Feature
Case Report
03/05/2014
Jason Salsamendi, MD, Ami Vakharia, MD, Adam N. Checkver, MD, Govindarajan Narayanan, MD, and Eric Peterson, MD
Jackson Memorial Hospital, Miami, Florida
Jason Salsamendi, MD, Ami Vakharia, M...
The authors theorize that a proximal and distal balloon occlusion technique was implemented along with a combination of coils and glue could be effective for pseudoaneurysm in various high-flow situations.
The authors theorize that a proximal and distal balloon occlusion technique was implemented along with a combination of coils and glue could be effective for pseudoaneurysm in various high-flow situations.
The authors theorize that a...
03/05/2014
Vascular Disease Management
